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Abstract
This study was conducted with the primary aim to distinguish patients with a true stroke versus a stroke mimic based
on clinical features and imaging. We conducted a retrospective caseecontrol study on 116 adult patients who received
alteplase (tPA) to treat acute stroke at our hospital. We further analyzed 79 patients with a normal computed tomography
angiography (CTA). Based on their magnetic resonance imaging (MRI) of the brain, they were divided into cases (stroke
mimics) and controls (true strokes).
Data were collected retrospectively by reviewing individual medical charts on the electronic medical record (EMR),
including age, gender, history of stroke, seizure, hypertension, diabetes, atrial ﬁbrillation, hyperlipidemia, presenting
NIH Stroke Scale/Score, hemorrhagic conversion, history of migraine, history of depression, sidedness of symptoms and
aphasia. Data were categorized to separate those who were later diagnosed to be stroke mimics by being- postictal,
encephalopathic, in acute migraine, suffered post-stroke recrudescence (PSR) due to metabolic insult, or had conversion
disorder when symptoms could not be attributed to any medical condition or mental illness.
Of the 79 study subjects, 48 (60%) were stroke mimics. The mean age of the cohort was 68.67 years, and 46.8% of the
study subjects were females. Based on the multivariate logistic regression analysis, factors associated with being a stroke
mimic were older age, history of migraine, and a history of prior stroke. In conclusion, increased attention to history and
clinical examination as the ﬁrst step can aid in the proper diagnosis of strokes versus stroke mimics.
Identifying stroke mimics early could help expedite hospital workup and prevent inadvertent investigations, reducing
hospital occupancy during the ongoing COVID-19 pandemic. We could potentially avoid the administration of tPA to
such patients, reducing both the cost and adverse effects of it. Every stroke can cause neurological deﬁcits, but every
deﬁcit need not be a stroke.
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1. Introduction

S

troke is a clinical diagnosis as endorsed by the
World Health Organization (WHO), deﬁned as
rapidly developing clinical signs of focal or global
disturbance in cerebral function lasting more than
24 hours or leading to death with no apparent cause
other than a vascular origin.1 It is ranked as the
second leading cause of death worldwide, with an
annual mortality of about 5.5 million.2 It is a medical
emergency, and an early diagnosis is of paramount
importance. This entails judicious clinical assess

ment supported by neuroimaging studies to conﬁrm
the diagnosis. For patients to receive time-critical
treatments such as thrombolytics, medical management, or surgical treatment of intracerebral hematoma and reversal of anticoagulation, patients
must be brought to the hospital rapidly, assessed
swiftly and accurately, and promptly undergo the
appropriate imaging/investigations.3,4
Stroke mimics (SM) are certain disorders that can
mimic clinical signs of a stroke, leading to misdiagnosis, delays, and inappropriate treatment. These
are pathological conditions that resemble stroke-
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like clinical presentations. However, their etiology is
not cerebrovascular.5 There is widespread use of
thrombolytic care in treating acute strokes in the
modern era; evidence indicates that as many as 15%
of patients treated with tissue plasminogen activator
(tPA) are actually SM, for which the therapy is not
an indication.6 This results in unnecessary diagnostic tests, invasive procedures, extended hospital
stays, and increasing patient care costs.2
Previous data from a multicentered European
study describes the proportion of SM as high as 30%
of all strokes.7 Similarly, in sub-Saharan Africa, a
hospital-based retrospective study conducted in
Nigeria found that among 142 patients with a WHO
clinical stroke diagnosis, 23.2% had SM, including
brain tumors, brain abscess, subdural hematomas,
hydrocephalus, and intracranial cysts.8 Other
described SM include seizures, syncope, metabolic
encephalopathies (such as hypoglycemia, hyponatremia, uremia, and hepatic encephalopathy), infectious disorders including meningoencephalitis,
and degenerative diseases, amongst other etiologies.9,10 Although such conditions physiologically
differ from actual strokes, the similarity of symptoms makes the diagnosis difﬁcult.9,11 Notable is
that, in sub-Saharan Africa, stroke is readily diagnosed purely on clinical grounds with no conﬁrmation due to limited access to brain imaging.12
Lack of proper and timely diagnosis of stroke or
stroke mimic can lead to irreversible complications.
Hence, we undertook the present study, with the
primary purpose of distinguishing stroke mimics
and true strokes based on clinical features and
imaging.

other contraindication to thrombolytic therapy and
the patient is within 4.5 hours of symptom onset, the
ER physician and the neurologist make a joint decision as to whether to administer tPA or transfer
the patient for mechanical thrombectomy. Patients
who receive tPA are monitored in the ICU for at
least 24 hrs. All patients undergo an MRI to conﬁrm
the presence or absence of an actual stroke. All
patients in our study followed this protocol.
Conversion disorder, also known as functional
neurological symptom disorder, was deﬁned as patients who presented with limb weakness or
numbness or speech disturbances usually precipitated by acute psycho-social stressors with no
organic etiology for neurological deﬁcits. These patients were assessed and diagnosed by the neurologist. Post-stroke recrudescence (PSR) refers to the
reappearance of previously resolved symptoms of a
remote ischemic stroke, usually triggered by
stressors, metabolic derangements, infection, or
fatigue.
Data were collected retrospectively by reviewing
individual medical charts on the EMR, including a
history of stroke, seizure, hypertension, diabetes,
atrial ﬁbrillation, hyperlipidemia, presenting NIH
Stroke Scale/Score, hemorrhagic conversion,
seizure episode after tPA administration, history of
migraine, history of depression, sidedness of
symptoms and aphasia. Data were categorized to
separate those who were later actually diagnosed to
be stroke mimics by being- postictal, encephalopathic, PSR due to metabolic insult, or had conversion disorder when symptoms could not be
attributed to any other medical condition.

2. Methods and deﬁnitions

2.1. Statistical analysis

This retrospective caseecontrol study was conducted after getting approval from the Institutional
Review Board. We identiﬁed 116 patients who
received alteplase (tissue plasminogen), 79 of the
patients who had a negative computed tomography
angiography (CTA) of their head were included for
further analysis. The included patients were divided
into cases (stroke mimics) and controls (true strokes)
based on magnetic resonance imaging (MRI) of the
brain. True strokes had relevant image ﬁndings on
MRI, whereas stroke mimics did not.
When patients are brought in with possible
stroke-like symptoms, a code stroke is activated
either by the emergency medical services (EMS) or
in the emergency room as per the hospital protocol.
Rapid assessment of the patient followed by CT of
the head without contrast and a CTA of the head
and neck. If there is no intracranial hemorrhage or

All statistical analyses were performed in SAS
version 9.4 software (SAS Institute, Cary, NC). We
used a multivariate logistic regression model to
assess the association between risk factors for being
a stroke mimic. Continuous variables included in
the model were age and NIHS score. Variables such
as gender, history of migraine, prior stroke, gender,
seizure history, and atrial ﬁbrillation were included
as dichotomous (yes or no) variables.

3. Results
116 patients received tPA, of which 79 patients
that had a normal CTA were included in the study,
and 39 patients with an abnormal head CTA were
excluded. The MRI of these 79 patients were studied, and they were divided into 31 true strokes and
48 stroke mimics. The distribution of study subjects
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Table 1. Distribution of study subjects based on demographics and history.
Patient Characteristics

Stroke mimic
(N ¼ 48)

True Stroke
(N ¼ 31)

Total
(N ¼ 79)

N (%)

N (%)

N (%)

Age Mean (SD)
Gender (Male)
Prior stroke
Hypertension
Diabetes
Atrial ﬁbrillation^
Hyperlipidemia
NIHS Score Mean (SD)
Hemorrhage conversion^
Seizure episode after tPa^
Aphasia
Facial droop
History of seizures^
Postictal^
Depression
Encephalopathy
Migraine^
Functional disorder
Post-stroke recrudescence

65.72 (17.8)
27 (56.2)
15 (31.2)
32 (66.6)
12 (25)
6 (12.5)
29 (60.4)
5.85 (5.1)
2 (4.1)
3 (6.2)
9 (18.7)
12 (25)
10 (20.8)
8 (16.6)
13 (27.0)
13 (27.0)
9 (18.75)
16 (33.3)
14 (29.17)

72.12 (12.7)
15 (48.39)
2 (6.4)
26 (83.8)
8 (25.8)
2 (6.4)
19 (61.9)
6.39 (4.4)
4 (12.9)
0
8 (25.8)
15 (48.39)
1 (3.2)
0
1 (3.2)
2 (6.4)
1 (3.23)
1 (3.2)
2 (6.45)

68.67 (16.07)
42 (53.1)
17 (21.2)
58 (73.4)
20 (25.3)
8 (10.1)
48 (60.7)
6 (4.82)
6 (7.5)
3 (3.8)
17 (21.5)
27 (34.1)
11 (13.9)
8 (10.1)
14 (17.7)
15 (18.9)
10 (12.6)
17 (21.5)
16 (20.2)

p-value

0.0813
0.4941
0.0088*
0.0910
0.9358
0.4703
0.9381
0.1501
0.2038
0.2756
0.4561
0.0324*
0.0428*
0.0196*
0.0067*
0.0224*
0.0791
0.0015*
0.0142*

*signiﬁcance.
^Fisher's exact test.

based on demographics and history was represented in Table 1.
For the continuous variable age, the mean (standard deviation) for study subjects in stroke mimic
and true stroke groups was 65.7 (17.8) and 72.12
(12.7). Similarly, the mean (standard deviation) for
NIHS score between the groups viz. stroke mimic &
true stroke was 5.85 ± 5.1 and 6.39 ± 4.4,
respectively.
The ﬁndings revealed as based on Fisher's exact
test and chi-square, there was a statistically signiﬁcant difference in the distribution of study subjects
between the groups (stroke mimic & true stroke) as
follows: facial droop (25%, p ¼ 0.0324), prior stroke
(31.25%, p ¼ 0.0088), history of seizures (20.83%,
p ¼ 0.0428) and history of depression (27.08%,
p ¼ 0.0067). Other variables like post ictal state
(16.6%, p ¼ 0.0196), encephalopathy (27.08%,
p ¼ 0.0224), conversion disorder (33.3%, p ¼ 0.0015)
and post stroke recrudescence (29.17%, p ¼ 0.0142)
were also signiﬁcant.
Logistic regression analysis showed that age
greater than 65 years (OR 0.195, p ¼ 0.087), history of
prior stroke (OR 8.635, p ¼ 0.0134), and history of
migraine (OR 11.254, p ¼ 0.0372) were positively
associated with being a stroke mimic (see Table 2).

4. Discussion
Although laboratory investigations and brain imaging can reﬁne the diagnosis, the clinical assess

Table 2. Analysis of risk factors for stroke mimics with clinical signs of
stroke.
Patient Characteristics

Odds Ratio
(95% Conﬁdence Interval)

p-value

Age >65 years
Female Gender
NIHS Score <7
History of prior stroke
History of Migraine
Seizure History
Atrial Fibrillation

0.195 (0.058, 0.661)
0.694 (0.212, 2.277)
1.099 (0.296, 4.072)
8.635 (1.563, 47.698)
11.254 (1.154, 109.776)
6.132 (0.639, 58.862)
3.253 (0.416, 25.442)

0.0087*
0.5466
0.8882
0.0134*
0.0372*
0.1161
0.2610

*p < 0.05.

ment remains vital because it is the ﬁrst step in the
diagnostic pathway and often directs the speed at
which more complex procedures are undertaken.
Brain imaging, even diffusion-weighted MRI, is not
infallible and may give confusing results.13 Despite
the need for a rapid and accurate clinical diagnosis
in the thrombolysis era, the process of clinical
assessment has received little formal study. Therefore, the present study was conducted with the
primary aim to distinguish the patients with stroke
mimics and true strokes based on clinical features
and imaging.
The median age of the stroke mimic patients was
65.72 years. This ﬁgure is higher than many other
studies,14e17 and their selective entry criteria may
explain this. The median NIHS score was 6.39 for
stroke mimics. This result was similar to the Okano
et al. study. They mentioned, “patients with strokelike symptoms, wherein the NIHS score was
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relatively low, and blood pressure was not elevated
in the ED, should be treated carefully with the
possibility of being a stroke mimic”.18
Patients with a history of facial droop, prior stroke,
known history of seizure, and history of depression
had statistically signiﬁcant differences between
stroke mimics and true strokes. Furthermore, conversion disorder, encephalopathy, and post-stroke
recrudescence from metabolic insults were signiﬁcant for being stroke mimics. Stroke mimics had
10.1 times higher odds of having a history of stroke
than true strokes. Similarly, stroke mimics are 12.9
times more likely to have a history of migraine than
true strokes.
Stroke mimics have less clearly deﬁned neurological symptoms that typically do not adhere to
well-deﬁned stroke syndromes.19 The suddenness
of onset is not always evident. Fluctuations in
severity are common and systemic signs including
drowsiness, confusion, agitation, and fever may be
present.20 Common symptoms include vertigo and
dizziness, altered level of consciousness, paresthesia
and numbness, monoplegia, speech dysfunction,
limb ataxia, headache, and visual disturbances.
In case a patient with history of migraines, presents with headache, aura, and vertigo, it would be
beneﬁcial to treat the migraine with NSAIDs and
antiemetics, conduct serial neurological examinations, or if possible, undergo an MRI rather than
directly administering tPA. Also, since conversion
disorder can be a stroke mimic, it would be beneﬁcial to take a detailed psychiatric history and serial
neurological examinations. In patients who have a
history of stroke, presenting again with a negative
CTA or a brain CT with no enlargement of the
previous infarcted area, it might be helpful to assess
whether presenting symptoms aren't residual from
the past stroke, as this might be post-stroke recrudescence. It would be appropriate to work up electrolyte derangements and screen for infections by
lab checks, chest x-ray, and urinalysis looking for
insults that can worsen old neurological deﬁcits in
patients with a distant history of stroke.
For the future, we propose large sample size
studies to be undertaken. Furthermore, a subgroup
analysis on common stroke mimic risk factors
should be done. Analysis with combining variables
like female gender and depression or female gander
and migraine or prior history of stroke and NIHS
score should be attempted. This may give valuable
information that a patient with these risk factors is
more likely to be a stroke mimic than having a
single risk factor. Given our limited sample size, we
could not do the above subgroup analysis.

The treatment of stroke-mimics depends on the
underlying condition outlined above, with common
conditions mistaken for an acute stroke. Patients with
inadvertently administered tPA should be stopped as
soon as the diagnosis becomes apparent. According
to protocol, if the drug has been infused, the patient
will still require close observation for 24 hours. The
diagnosis must be correctly recorded, especially in
patients with conversion disorder with a high likelihood of repeated hospital visits. Recurrence is also
likely with migraines, focal seizures, and patients
with a pre-existing stroke (recrudescence). Treatment
of the underlying conditions like infections, electrolyte derangements is vital to decrease the risk of
recurrence and presentation of a stroke mimic again.
The average cost of hospitalization for a patient
with stroke is >$20,000 ± $23,256 stay.21 The difference is due to complications during the stay, hemorrhagic or ischemic stroke. According to leading
reports, this, when compared to the cost of an MRI
brain, is around $3000-$11000.
By incorporating above mentioned risk factors
into the clinical exam and increasing awareness of
stroke mimics, we intend to help reduce this burden
on healthcare.

5. Conclusion
While not easy to conﬁrm a stroke in the acuity of
the emergency room or medical ﬂoors, the standard
of care requires patients to undergo a CT stroke
protocol before tPA administration. Aura before the
onset of symptoms, headaches, or a prior history of
depression might point away from a stroke when
the CTA is normal.
Patients admitted with suspected stroke, end up
undergoing extensive workup for etiology, risk
stratiﬁcation, judicious blood pressure management, lipid proﬁle, and diabetes mellitus screening.
They undergo evaluation for carotid artery disease,
cardiac echocardiography to rule out a PFO and are
monitored for arrhythmias on telemetry. They undergo evaluation by speech, physical and occupational therapy with a discharge plan to follow up
with a neurologist.
Identifying stroke mimics early could help expedite hospital workup and prevent inadvertent investigations and use of hospital workforce, reducing
hospital occupancy during the ongoing COVID-19
pandemic.
Our study ﬁndings reiterate the importance of
detailed history and clinical examination as the ﬁrst
step in improving an accurate diagnosis of a
stroke mimic. This could potentially avoid the

administration of tPA to such patients, reducing
both the cost and adverse effects of it. Every stroke
can cause neurological deﬁcits, but every deﬁcit
need not be a stroke.
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